| Llista de productes | |||
| API i intermedis | |||
| Nom del producte | Cas núm. | Qualitat | Observacions |
| 9α-OH-4AD | 560-62-3 | ≥98,5% | |
| 17α-hidroxiprogesterona | 604-09-1 | ≥98,0% | |
| Aciclovir | 59277-89-3 | USP/EP/CP | |
| En pols d’amoxicil·lina/compactat/micronitzat | 61336-70-7 | BP+a casa | GMP |
| Clorhidrat amb ambroxol | 23828-92-4 | USP/BP | GMP |
| Axitinib | 319460-85-0 | ||
| Avatrombopag maleat | 677007-74-8 | ||
| anecohe acetat | 7753-60-8 | ≥ 98,5% | |
| Bendazol HCl | 1212-48-2 | A casa | |
| Clorhidrat de capmatinib | 1865733-40-9 | ||
| Ceftiofur sodi | 104010-37-9 | ||
| Clorhidrat ceftiofur | 103980-44-5 | ||
| Àcid lliure de ceftiofur | 80370-57-6 | ||
| Ceftriaxona sodi | 74578-69-1 | Usp | GMP |
| Cefotaxime sodi | 64485-93-4 | Usp | GMP |
| Cefquinoma sulfat | 118443-89-3 | ||
| Cefaloni | 5575-21-3 | ||
| Ciclopirox | 29342-05-0 | USP/EP | Cep |
| Ciclopirox olamina | 41621-49-2 | USP/EP/CP | Cep |
| Clozapina | 5786-21-0 | USP/EP | DMF |
| Crizotinib | 877399-52-5 | ||
| Mesilat de dabrafenib | 1195768-06-9 | ||
| Diczuril | 101831-37-2 | USP/EP/BP | |
| Doremectina | 117704-25-3 | USP/EP/BP | |
| Doxycycline HCl | 98079-52-8 | USP/EP/BP | |
| Doxofylline | 69975-86-6 | USP/EP | |
| Monohidrat de Tosilat d'Edoxaban | 1229194-11-9 | USP/EP | |
| Entrectinib | 1108743-60-7 | ||
| Famciclovir | 104227-87-4 | USP/CP | KDMF USDMF |
| Finerenone | 1050477-31-0 | ||
| Flunixin Meglumine | 42461-84-7 | Usp | GMP |
| Furaltadona | 139-91-3 | ≥98% | |
| Furalzolidona | 67-45-8 | USP/EP/BP | |
| Gamithromycin | 145435-72-9 | ||
| Ganciclovir | 82410-32-0 | USP/BP/CP | USDMF EDMF |
| Innapamida | 26807-65-8 | ||
| Inositol hexanicotiante | 6556-11-2 | Usp | |
| Lacosamida | 175481-36-4 | USP/EP | |
| Mesilat lenvatinib | 857890-39-2 | ||
| Letermovir | 917389-32-3 | ||
| Loxoprofen sodi | 80382-23-6 | ||
| Marbofloxacina | 115550-35-1 | Usp | |
| Mobocertinib succinat | 2389149-74-8 | ||
| Molnupiravir | 2349386-89-4 | ||
| Nafazolina | 835-31-4 | USP/EP | |
| Sulfat de neomicina | 1405-10-3 | USP/BP/EP | |
| Penciclovir | 39809-25-1 | CFDA | KDMF |
| Propofol | 2078-54-8 | USP/EP | |
| Roxadustat | 808118-40-3 | ||
| Mesilat de seguretat | 202825-46-5 | ||
| Selpercatinib | 2152628-33-4 | ||
| Sulfat d’estreptomicina | 3810-74-0 | USP/EP | |
| Tenofovir alafenamide fumarat | 1392275-56-7 | ||
| Tiamulin Hydrogen Fumarate | 55297-95-5 | USP/EP | EDMF/FDA |
| Tiamulin HF 80%/10% | 55297-95-5 | A casa | |
| Tianeptí | 66981-73-5 | ||
| Fosfat de tilmicosina | 137330-13-3 | USP/EP/BP | |
| Tartrat de tilosina | 74610-55-2 | USP/EP/BP | |
| Fosfat de tilosina | 1405-53-4 | USP/EP/BP | |
| Tilvalosina | 63409-12-1 | USP/EP | |
| Tucatinib | 937263-43-9 | ||
